Key Performance
More- Earnings Score: 54
- Momentum Score: 33
- True Yield: N/A
- Financial Health Score: 22
%20scale(1,1)}%2025%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(1,1)}}%20%23ewMkZ6d8Hun3_ts%20{animation:%20ewMkZ6d8Hun3_ts__ts%204000ms%20linear%20infinite%20normal%20forwards}@keyframes%20ewMkZ6d8Hun3_ts__ts%20{%200%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}%2025%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}}%20]]%3e%3c/style%3e%3cdefs%3e%3clinearGradient%20id='ewMkZ6d8Hun2-fill'%20x1='12.5'%20y1='23.5001'%20x2='-0.868518'%20y2='16.4047'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun2-fill-0'%20offset='0%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun2-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3clinearGradient%20id='ewMkZ6d8Hun3-fill'%20x1='31.5059'%20y1='27.1026'%20x2='10.2884'%20y2='14.9373'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun3-fill-0'%20offset='4.7%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun3-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20id='ewMkZ6d8Hun2_ts'%20transform='translate(24.943161,19.954806)%20scale(1,1)'%3e%3cpath%20d='M14.8466,29.2814c0,0-14.408088-4.6983-12.05895-19.79995c0,0,1.50345,4.85085,4.13448,5.30845s-2.03592,4.6373,7.92447,14.4915Z'%20transform='translate(-24.943161,-19.954806)'%20fill='url(%23ewMkZ6d8Hun2-fill)'/%3e%3c/g%3e%3cg%20id='ewMkZ6d8Hun3_ts'%20transform='translate(24.9787,20.012362)%20scale(1,1)'%3e%3cpath%20d='M37.4922,21.9282l4.0719.244v-12.81353C31.0713,3.28748,17.7595,7.6502,17.7595,7.6502c.3445-4.51526-3.5707-5.52204-3.5707-5.52204c2.5371,1.52542.3132,6.22373.3132,6.22373C13.0299,0.084092,0,1.02986,0,1.02986C8.92672,4.35528,6.70287,7.98579,6.8908,16.6197c.18794,8.6034,8.3943,12.9966,8.3943,12.9966l-6.60895-.2441v13.2407c0,0,5.48135,2.3797,13.68765,3.1729v-22.3017h-4.4477c-1.0023,0-1.942-.8237-1.942-1.8v-5.7356c0-.9763.9397-1.8,1.942-1.8h4.4477v-1.3424h5.0115v1.3424h5.0115c1.0023,0,1.848.7932,1.848,1.8v5.7356c0,.9763-.8144,1.8-1.848,1.8h-5.0115v22.5153h.2819c11.1192-.0611,15.9428-7.3221,16.256-13.3017.4698-7.7492-6.421-10.7695-6.421-10.7695Z'%20transform='translate(-24.9787,-20.012361)'%20fill='url(%23ewMkZ6d8Hun3-fill)'/%3e%3c/g%3e%3c/svg%3e)
Latest Research & News
Exponent, Inc. announced executive leadership changes effective May 1, 2026, promoting John Pye to President and Eric Anderson to Chief Financial Officer, both reporting to CEO Catherine Corrigan. Richard Schlenker will transition from CFO to Executive Vice President and stand for Board election. Paul Johnston will retire from the Board, with Karen Richardson becoming Chairman at the June 4, 2026 Annual Meeting.
04/06/2026, 4:35 PM • GlobeNewswire
Exponent Increases Quarterly Dividend Payment from $0.30 to $0.31 per Share for Q1 2026
Exponent Inc. (NASDAQ: EXPO) announced that its Board of Directors has increased its quarterly cash dividend from $0.30 to $0.31 per share, effective for Q1 2026. The dividend will be paid on March 20, 2026 to shareholders of record as of March 6, 2026. CEO Dr. Catherine Corrigan attributed the increase to strong market drivers and confidence in the company's scientific and engineering capabilities.
02/05/2026, 4:05 PM • Benzinga
Exponent Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Exponent (NASDAQ: EXPO) reported strong Q4 2025 results with total revenues increasing 7.8% to $147.4 million and net income rising to $24.8 million ($0.49 per diluted share). For fiscal year 2025, revenues grew 4.2% to $582.0 million with net income of $106.0 million ($2.07 per diluted share). The company increased its quarterly dividend from $0.30 to $0.31 and provided guidance for FY2026 expecting high-single-digit revenue growth with EBITDA margins of 27.6% to 28.1%.
02/05/2026, 4:05 PM • Benzinga
Independent Investment Manager Sells $24.6 Million of Exponent Stock, According to Recent Filing
Conestoga Capital Advisors sold 344,631 shares of Exponent, valued at $24.63 million, reducing its stake from 2.99% to 2.63% of its portfolio in Q3 2025. The sale comes amid Exponent's underperformance compared to the S&P 500.
10/26/2025, 12:07 PM • The Motley Fool
Exponent (EXPO) Q2 Revenue Rises 1%
Exponent reported a modest 1% revenue increase to $142.0 million in Q2 FY2025, with declining profitability due to rising operating costs. The company saw stable performance driven by reactive consulting services, particularly in construction and medical devices, while experiencing softness in proactive services.
08/01/2025, 3:11 PM • The Motley Fool
